Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic … MH Forouzanfar, A Afshin, LT Alexander, HR Anderson, ZA Bhutta, ... The lancet 388 (10053), 1659-1724, 2016 | 9698* | 2016 |
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of … T Vos, C Allen, M Arora, RM Barber, ZA Bhutta, A Brown, A Carter, ... The lancet 388 (10053), 1545-1602, 2016 | 6490* | 2016 |
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global … H Wang, M Naghavi, C Allen, RM Barber, ZA Bhutta, A Carter, DC Casey, ... The lancet 388 (10053), 1459-1544, 2016 | 5614 | 2016 |
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015 MB Reitsma, N Fullman, M Ng, JS Salama, A Abajobir, KH Abate, ... The Lancet 389 (10082), 1885-1906, 2017 | 1957 | 2017 |
Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 NJ Kassebaum, RM Barber, ZA Bhutta, L Dandona, PW Gething, SI Hay, ... The lancet 388 (10053), 1775-1812, 2016 | 1303 | 2016 |
Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of … H Wang, ZA Bhutta, MM Coates, M Coggeshall, L Dandona, K Diallo, ... The Lancet 388 (10053), 1725-1774, 2016 | 889 | 2016 |
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015 H Wang, TM Wolock, A Carter, G Nguyen, HH Kyu, E Gakidou, SI Hay, ... The lancet HIV 3 (8), e361-e387, 2016 | 818 | 2016 |
Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 SS Lim, K Allen, ZA Bhutta, L Dandona, MH Forouzanfar, N Fullman, ... The Lancet 388 (10053), 1813-1850, 2016 | 683 | 2016 |
Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis AB Mekonnen, AJ McLachlan, EB Jo-anne BMJ open 6 (2), e010003, 2016 | 572 | 2016 |
Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the … RM Barber, N Fullman, RJD Sorensen, T Bollyky, M McKee, E Nolte, ... The lancet 390 (10091), 231-266, 2017 | 545 | 2017 |
Pharmacy‐led medication reconciliation programmes at hospital transitions: a systematic review and meta‐analysis AB Mekonnen, AJ McLachlan, JE Brien Journal of clinical pharmacy and therapeutics 41 (2), 128-144, 2016 | 377 | 2016 |
The COVID-19 pandemic and healthcare systems in Africa: a scoping review of preparedness, impact and response GA Tessema, Y Kinfu, BA Dachew, AG Tesema, Y Assefa, KA Alene, ... BMJ global health 6 (12), e007179, 2021 | 236 | 2021 |
Impact of electronic medication reconciliation interventions on medication discrepancies at hospital transitions: a systematic review and meta-analysis AB Mekonnen, TB Abebe, AJ McLachlan, JE Brien BMC medical informatics and decision making 16, 1-14, 2016 | 122 | 2016 |
Potentially inappropriate prescribing and its associations with health‐related and system‐related outcomes in hospitalised older adults: a systematic review and meta‐analysis AB Mekonnen, B Redley, B de Courten, E Manias British journal of clinical pharmacology 87 (11), 4150-4172, 2021 | 114 | 2021 |
Adverse drug events and medication errors in African hospitals: a systematic review AB Mekonnen, TM Alhawassi, AJ McLachlan, JE Brien Drugs-real world outcomes 5, 1-24, 2018 | 104 | 2018 |
Implementing ward based clinical pharmacy services in an Ethiopian University Hospital AB Mekonnen, EA Yesuf, PS Odegard, SS Wega Pharmacy practice 11 (1), 51, 2013 | 87 | 2013 |
Risk factors for COVID-19 infection, disease severity and related deaths in Africa: a systematic review HA Gesesew, DN Koye, DM Fetene, M Woldegiorgis, Y Kinfu, AB Geleto, ... BMJ open 11 (2), e044618, 2021 | 81 | 2021 |
Short-and long-term outcomes in infective endocarditis patients: a systematic review and meta-analysis TM Abegaz, AS Bhagavathula, EA Gebreyohannes, AB Mekonnen, ... BMC Cardiovascular Disorders 17, 1-12, 2017 | 81 | 2017 |
Self-reported adverse drug reactions and their influence on highly active antiretroviral therapy in HIV infected patients: a cross sectional study WT Tadesse, AB Mekonnen, WH Tesfaye, YT Tadesse BMC pharmacology and Toxicology 15, 1-9, 2014 | 78 | 2014 |
High fasting plasma glucose, diabetes, and its risk factors in the eastern mediterranean region, 1990–2013: findings From the Global Burden of Disease Study 2013 M Moradi-Lakeh, MH Forouzanfar, C El Bcheraoui, F Daoud, A Afshin, ... Diabetes care 40 (1), 22-29, 2017 | 70 | 2017 |